Breakout Alert: Generex Biotech GNBT Seeking FDA Approval

Finally there is life in the penny stock of Generex Biotechnology Corp. (OTC: GNBT) after the Breast Cancer Vaccine makers made three seperate announcements.  GNBT stock currently trading up 17.84% at 0.109 on more than 5x the 10 day aveage volume after the Company announced an End-of-Phase II meeting has been scheduled with the FDA in respect of the Phase II clinical ...

Continue Reading →
0

Cheap Biotech Stocks: Generex Biotechnology (GNBT)

Shares in Generex Biotechnology (OTC: GNBT) have not been able to rally since their January run when the penny stock hit $0.277. We profiled GNBT as one of our penny stock picks profiled in our newsletter when shares were just $0.1575 securing a 75% gain bottom-to-top. GNBT closed with a slight gain of 0.39% at $0.13 in the ...

Continue Reading →
0

Generex Biotechnology (GNBT) Closer to Curing Breast Cancer

One penny stock profiled here as a good penny stock to watch was Generex Biotechnology Corp. (OTCBB: GNBT.OB) who filed their 10-Q yesterday for the quarter ended January 31, 2012. As most biotech companies researching cures to certain cancers, GNBT has been struggling to meet its cash requirements for years but may be on the cusp of announcing a major breakthrough in the fight against breast cancer.

On January ...

Continue Reading →
0